Gabexate mesilate is a synthetic serine protease inhibitor used therapeutically to manage conditions such as acute pancreatitis and disseminated intravascular coagulation by inhibiting key enzymes including… Read more
Gabexate mesilate is a synthetic serine protease inhibitor used therapeutically to manage conditions such as acute pancreatitis and disseminated intravascular coagulation by inhibiting key enzymes including trypsin, kallikrein, and thrombin. Ensuring the efficacy and safety of this therapeutic agent requires rigorous analytical evaluation throughout the development and manufacturing lifecycle. This category offers essential reference standards for the drug substance, alongside a comprehensive range of pharmacopeial and non-pharmacopeial impurities and metabolites required for accurate impurity profiling. Additionally, stable isotope labelled compounds are provided to support advanced analytical testing, method validation, and quantitative mass spectrometry applications. These high-quality materials are critical for laboratories performing release testing, stability studies, and quality control, enabling precise monitoring of the drug’s degradation and ensuring compliance with stringent regulatory standards for pharmaceutical quality.